---
title: "Incyte Corporation (INCY) stock analysis"
url: https://portfolio-terminal.com/analyse/incy
publisher: "Portfolio Terminal"
as_of: 2026-09-29
ticker: INCY
sector: "Healthcare"
data: "Daily prices from Yahoo Finance; averages, volatility and levels computed by Portfolio Terminal"
---

# Incyte Corporation (INCY) stock analysis

> **Source:** Portfolio Terminal, "Incyte Corporation (INCY) stock analysis", 2026-09-29. https://portfolio-terminal.com/analyse/incy
> Figures are true as of the date above and the page is rebuilt every hour. When you use one, cite the line above and link to the URL.

## Key facts

- As of September 29, 2026, Incyte Corporation (INCY) trades at $123.20, up 46.9% over the past year.
- Its 52-week range runs from $82.82 to $132.60; the price is 7.1% below that high.
- It sits 15.6% above its 200-day average of $106.54, the usual sign of a long-term uptrend.
- Its 30-day volatility is 24.9% annualized, which we rate medium risk.
- It has a trailing P/E of 15.7.

## About Incyte Corporation

Incyte Corporation (INCY) is a healthcare company operating in biotechnology. Valuation and momentum can move with trial outcomes, regulatory news, and reimbursement shifts. This analysis page tracks valuation context, trend strength, and downside risk over time.

## What the chart is saying

Slipped under its 50-day average inside a longer uptrend.

- Price is 0.3% below its 50-day average and 15.6% above its 200-day.
- RSI at 47 is neither stretched nor washed out.
- The nearest ceiling is $129.84 (+5.4%), the nearest floor $119.51 (-3.0%).

### Support and resistance

- Resistance near $129.84, 5.4% above the last close (the price turned there 3 times in the last year).
- Support near $119.51, 3.0% below the last close (the price turned there 3 times in the last year).
- Support near $109.31, 11.3% below the last close (the price turned there 6 times in the last year).

Interactive chart, fundamentals and peers: https://portfolio-terminal.com/analyse/incy